Experimental studies have reported that the delayed onset of antidepressants action is associated with a slowly developed increase and rearrangements of synaptic strength in the depression-related circuits, requiring changes in the gene expression and protein translation that are dependent, to some extent, on the engagement of BDNF/TrkB pathways [13,14]. The gene discussed is BDNF; the disease is depressive symptom measurement.